MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer.

Zuo TaoHuandan SuoLei ZhangZining JinZhen WangDanyu WangMing WuNanxi PengYujie Zhao Bo Chen

Published in: OncoTargets and therapy (2020)

The expression of MRPL13 mRNA is upregulated in BC tissues, and the expression level of MRPL13 is significantly related to the clinicopathological factors of patients. High MRPL13 expression is a poor prognostic factor for BC, and it can be used as a molecular marker for prognosis judgment and as a potential therapeutic target.

Keyphrases

prognostic factors
poor prognosis
binding protein
end stage renal disease
ejection fraction
chronic kidney disease
papillary thyroid
peritoneal dialysis
young adults
patient reported outcomes
drug induced
lymph node metastasis
childhood cancer